Compare FOLD & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOLD | NMRK |
|---|---|---|
| Founded | 2002 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | 2007 | 2017 |
| Metric | FOLD | NMRK |
|---|---|---|
| Price | $14.19 | $17.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $29.79 | $19.40 |
| AVG Volume (30 Days) | ★ 14.8M | 1.3M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.69% |
| EPS Growth | N/A | ★ 94.50 |
| EPS | N/A | ★ 0.59 |
| Revenue | $598,704,000.00 | ★ $3,160,782,000.00 |
| Revenue This Year | $21.49 | $21.82 |
| Revenue Next Year | $18.25 | $10.10 |
| P/E Ratio | ★ N/A | $29.70 |
| Revenue Growth | ★ 21.28 | 20.95 |
| 52 Week Low | $5.51 | $9.65 |
| 52 Week High | $14.36 | $19.84 |
| Indicator | FOLD | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 91.10 | 53.56 |
| Support Level | $10.64 | $16.98 |
| Resistance Level | $11.14 | $17.87 |
| Average True Range (ATR) | 0.36 | 0.56 |
| MACD | 0.28 | 0.07 |
| Stochastic Oscillator | 96.46 | 68.00 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.